5 research outputs found

    Desarrollo de un programa inform谩tico para estudios nutricionales Development of a software program for nutrition studies

    No full text
    Se desarroll贸 el programa inform谩tico Interfood v. 1.3 para procesar la informaci贸n alimentaria y generar datos sobre el consumo diet茅tico -en t茅rminos de alimentos, nutrientes y sustancias fitoqu铆micas- v谩lidos para realizar estudios nutricionales y epidemiol贸gicos. El programa se basa en tres componentes fundamentales: el cuestionario de frecuencia de consumo alimentario (CFCA); una base de datos de alimentos frecuentes y su contenido en 131 compuestos (macro y micronutrientes y sustancias fitoqu铆micas); y una base de datos relacional que asocia la informaci贸n del CFCA con la base de datos de alimentos. De esta forma, el programa inform谩tico Interfood calcula la cantidad de cada uno de los alimentos y los nutrientes y las sustancias fitoqu铆micas que una persona consume por d铆a, semana y mes. Interfood es un programa de c贸digo abierto, por lo que sus bases de datos se pueden modificar y actualizar de acuerdo con las necesidades de la investigaci贸n. Este programa ya ha demostrado su utilidad en diversas investigaciones nutricionales y epidemiol贸gicas.The Interfood v. 1.3 software program was developed to process nutrition information and generate data on dietary intakes-in terms of food, nutrients, and phytochemical substances-valid for conducting studies on nutrition and epidemiology. The program has three basic components: the dietary intake frequency questionnaire CFCA); a database of common foods and their composition of 131 possible substances (macro- and micronutrients and phytochemicals); and a relational database that links the CFCA data with the food database. In this manner, the Interfood software program calculates the amount of food, nutrients, and phytochemical substances consumed by an individual daily, weekly, and monthly. Interfood is an open-source program; as such, the database can be modified and updated according to study requirements. This program has already proven useful to various studies of nutrition and epidemiology

    Initial invasive or conservative strategy for stable coronary disease

    No full text
    BACKGROUND Among patients with stable coronary disease and moderate or severe ischemia, whether clinical outcomes are better in those who receive an invasive intervention plus medical therapy than in those who receive medical therapy alone is uncertain. METHODS We randomly assigned 5179 patients with moderate or severe ischemia to an initial invasive strategy (angiography and revascularization when feasible) and medical therapy or to an initial conservative strategy of medical therapy alone and angiography if medical therapy failed. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. A key secondary outcome was death from cardiovascular causes or myocardial infarction. RESULTS Over a median of 3.2 years, 318 primary outcome events occurred in the invasive-strategy group and 352 occurred in the conservative-strategy group. At 6 months, the cumulative event rate was 5.3% in the invasive-strategy group and 3.4% in the conservative-strategy group (difference, 1.9 percentage points; 95% confidence interval [CI], 0.8 to 3.0); at 5 years, the cumulative event rate was 16.4% and 18.2%, respectively (difference, 121.8 percentage points; 95% CI, 124.7 to 1.0). Results were similar with respect to the key secondary outcome. The incidence of the primary outcome was sensitive to the definition of myocardial infarction; a secondary analysis yielded more procedural myocardial infarctions of uncertain clinical importance. There were 145 deaths in the invasive-strategy group and 144 deaths in the conservative-strategy group (hazard ratio, 1.05; 95% CI, 0.83 to 1.32). CONCLUSIONS Among patients with stable coronary disease and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years. The trial findings were sensitive to the definition of myocardial infarction that was used

    Health-status outcomes with invasive or conservative care in coronary disease

    No full text
    BACKGROUND In the ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not reduce clinical events among patients with stable ischemic heart disease and moderate or severe ischemia. A secondary objective of the trial was to assess angina-related health status among these patients. METHODS We assessed angina-related symptoms, function, and quality of life with the Seattle Angina Questionnaire (SAQ) at randomization, at months 1.5, 3, and 6, and every 6 months thereafter in participants who had been randomly assigned to an invasive treatment strategy (2295 participants) or a conservative strategy (2322). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate differences between the treatment groups. The primary outcome of this health-status analysis was the SAQ summary score (scores range from 0 to 100, with higher scores indicating better health status). All analyses were performed in the overall population and according to baseline angina frequency. RESULTS At baseline, 35% of patients reported having no angina in the previous month. SAQ summary scores increased in both treatment groups, with increases at 3, 12, and 36 months that were 4.1 points (95% credible interval, 3.2 to 5.0), 4.2 points (95% credible interval, 3.3 to 5.1), and 2.9 points (95% credible interval, 2.2 to 3.7) higher with the invasive strategy than with the conservative strategy. Differences were larger among participants who had more frequent angina at baseline (8.5 vs. 0.1 points at 3 months and 5.3 vs. 1.2 points at 36 months among participants with daily or weekly angina as compared with no angina). CONCLUSIONS In the overall trial population with moderate or severe ischemia, which included 35% of participants without angina at baseline, patients randomly assigned to the invasive strategy had greater improvement in angina-related health status than those assigned to the conservative strategy. The modest mean differences favoring the invasive strategy in the overall group reflected minimal differences among asymptomatic patients and larger differences among patients who had had angina at baseline